Detalhe da pesquisa
1.
Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study.
Ther Adv Hematol
; 11: 2040620720955002, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33101618
2.
Development of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Content Validity.
Front Pharmacol
; 11: 209, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32210809
3.
Hematological Malignancy Specific Patient-Reported Outcome Measure (HM-PRO): Construct Validity Study.
Front Pharmacol
; 11: 1308, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33013368
4.
Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PRO.
Front Pharmacol
; 11: 571066, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33192513
5.
Paper and electronic versions of HM-PRO, a novel patient-reported outcome measure for hematology: an equivalence study.
J Comp Eff Res
; 8(7): 523-533, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31037971